(Q37469283)

20 August 2017

1 reference

title

The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies (English)

1 reference

20 August 2017

Pizzo PA

1

1 reference

20 August 2017

Rubin M

series ordinal

2

1 reference

20 August 2017

Freifeld A

series ordinal

3

1 reference

20 August 2017

Walsh TJ

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

The Journal of Pediatrics

20 August 2017

published in

1 reference

20 August 2017

volume

119

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

679-694

1 reference

Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Alpha-hemolytic streptococci: clinical significance in the cancer patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Increasing incidence of Gram-positive sepsis in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Use of routine chest radiography in the evaluation of fever in neutropenic pediatric oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Patterns of oropharyngeal and fecal flora in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Rapid migration of 111indium-labeled granulocytes to sites of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Atypical mycobacterial infections of Hickman catheter exit sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Primary cutaneous aspergillosis associated with Hickman intravenous catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Aztreonam therapy in neutropenic patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Beta-Lactam antibiotics (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Drug therapy. Beta-lactam antibiotics (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Emerging resistance to fluoroquinolones in staphylococci: an alert

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Approaching the controversies in antibacterial management of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Anorectal Infections in Patients with Malignant Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Treatment of gram-positive septicemia in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Right lower quadrant pain in young patients with leukemia. A surgical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Emergence of Clostridium tertium as a pathogen in neutropenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Nosocomial acquisition of Clostridium difficile infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Disease associated with Clostridium difficile infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Esophageal infections in immunosuppressed patients after marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Bacterial esophagitis in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppressed pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

A randomized trial of open lung biopsy versus empiric antimicrobial therapy in cancer patients with diffuse pulmonary infiltrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Considerations for the prevention of infectious complications in patients with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Live attenuated varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

The risk of zoster after varicella vaccination in children with leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Immunization strategies for the immunocompromised host: the need for immunoadjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Hematopoietic growth factors. Biology and clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Acceleration of neutrophilic granulocyte recovery after bone-marrow transplantation by administration of recombinant human granulocyte colony-stimulating factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

The polymerase chain reaction: amplifying our options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

7 January 2021

Perspective on the management of catheter-related infections in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

7 January 2021

Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

7 January 2021

Bacteremia caused by non-sporulating anaerobes in cancer patients. A 12-year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

7 January 2021

Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

7 January 2021

Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980281-1

7 January 2021

10.1016/S0022-3476(05)80281-1

Identifiers

DOI

1 reference

20 August 2017

1 reference